US HB2732 | 2019-2020 | 116th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 9-1)
Status: Introduced on May 14 2019 - 25% progression, died in committee
Action: 2019-06-26 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 14 2019 - 25% progression, died in committee
Action: 2019-06-26 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose.
Title
LABEL Opioids Act Lessening Addiction By Enhancing Labeling Opioids Act of 2019
Sponsors
| Rep. Greg Stanton [D-AZ] | Rep. Ben McAdams [D-UT] | Rep. Susan Wild [D-PA] | Rep. Jeff Van Drew [R-NJ] |
| Rep. Mary Gay Scanlon [D-PA] | Rep. Elaine Luria [D-VA] | Rep. Betty McCollum [D-MN] | Rep. Jahana Hayes [D-CT] |
| Rep. Brad Sherman [D-CA] | Rep. Collin Peterson [D-MN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-06-26 | House | Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. |
| 2019-05-15 | House | Referred to the Subcommittee on Health. |
| 2019-05-14 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-05-14 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-05-14 | House | Introduced in House |
Same As/Similar To
SB1449 (Same As) 2019-05-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory procedures
Consumer affairs
Crime and law enforcement
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health information and medical records
Prescription drugs
Consumer affairs
Crime and law enforcement
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health information and medical records
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/2732/all-info |
| Text | https://www.congress.gov/116/bills/hr2732/BILLS-116hr2732ih.pdf |
